Trial Profile
Effect of Ranibizumab and Scatter Laser Photocoagulation or Ranibizumab Alone in Patients with Retinal Vein Occlusion: The RELATE Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Sep 2016
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Branch retinal vein occlusion; Central retinal vein occlusion; Retinal oedema
- Focus Therapeutic Use
- Acronyms RELATE
- Sponsors Genentech
- 13 Sep 2016 New trial record